Stewart CF - Search Results

1

Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours.

Panetta JC, Roberts JK, Huang J, Lin T, Daryani VM, Harstead KE, Patel YT, Onar-Thomas A, Campagne O, Ward DA, Broniscer A, Robinson G, Gajjar A, Stewart CF. Panetta JC, et al. Among authors: stewart cf. Br J Clin Pharmacol. 2020 Feb;86(2):362-371. doi: 10.1111/bcp.14160. Epub 2020 Jan 8. Br J Clin Pharmacol. 2020. PMID: 31657864 Free PMC article.

2

Disposition of high-dose methotrexate in an obese cancer patient.

Fleming RA, Eldridge RM, Johnson CE, Stewart CF. Fleming RA, et al. Among authors: stewart cf. Cancer. 1991 Sep 15;68(6):1247-50. doi: 10.1002/1097-0142(19910915)68:6<1247::aid-cncr2820680611>3.0.co;2-o. Cancer. 1991. PMID: 1714790

3

Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis.

Stewart CF, Fleming RA, Arkin CR, Evans WE. Stewart CF, et al. Clin Pharmacol Ther. 1990 Apr;47(4):540-6. doi: 10.1038/clpt.1990.69. Clin Pharmacol Ther. 1990. PMID: 2328562

4

Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors.

Baker SD, Heideman RL, Crom WR, Kuttesch JF, Gajjar A, Stewart CF. Baker SD, et al. Among authors: stewart cf. Cancer Chemother Pharmacol. 1996;37(3):195-202. doi: 10.1007/BF00688317. Cancer Chemother Pharmacol. 1996. PMID: 8529278

5

Topoisomerase I interactive drugs in children with cancer.

Stewart CF, Zamboni WC, Crom WR, Gajjar A, Heideman RL, Furman WL, Meyer WH, Houghton PJ, Pratt CB. Stewart CF, et al. Invest New Drugs. 1996;14(1):37-47. doi: 10.1007/BF00173681. Invest New Drugs. 1996. PMID: 8880392 Review.

6

Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma.

Zamboni WC, Gajjar AJ, Heideman RL, Beijnen JH, Rosing H, Houghton PJ, Stewart CF. Zamboni WC, et al. Among authors: stewart cf. Clin Cancer Res. 1998 Mar;4(3):783-9. Clin Cancer Res. 1998. PMID: 9533548

7

A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma.

Zamboni WC, Gajjar AJ, Mandrell TD, Einhaus SL, Danks MK, Rogers WP, Heideman RL, Houghton PJ, Stewart CF. Zamboni WC, et al. Among authors: stewart cf. Clin Cancer Res. 1998 Oct;4(10):2537-44. Clin Cancer Res. 1998. PMID: 9796988

8

Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors.

Zamboni WC, Bowman LC, Tan M, Santana VM, Houghton PJ, Meyer WH, Pratt CB, Heideman RL, Gajjar AJ, Pappo AS, Stewart CF. Zamboni WC, et al. Among authors: stewart cf. Cancer Chemother Pharmacol. 1999;43(6):454-60. doi: 10.1007/s002800050923. Cancer Chemother Pharmacol. 1999. PMID: 10321504

9

Topotecan-filgrastim combination is an effective regimen for mobilizing peripheral blood stem cells.

Yeoh EJ, Cunningham JM, Yee GC, Hunt D, Houston JA, Richardson SL, Stewart CF, Houghton PJ, Bowman LC, Gajjar AJ. Yeoh EJ, et al. Among authors: stewart cf. Bone Marrow Transplant. 2001 Sep;28(6):563-71. doi: 10.1038/sj.bmt.1703202. Bone Marrow Transplant. 2001. PMID: 11607769 Clinical Trial.

10

Phase I study of combination topotecan and carboplatin in pediatric solid tumors.

Athale UH, Stewart C, Kuttesch JF, Moghrabi A, Meyer W, Pratt C, Gajjar A, Heideman RL. Athale UH, et al. J Clin Oncol. 2002 Jan 1;20(1):88-95. doi: 10.1200/JCO.2002.20.1.88. J Clin Oncol. 2002. PMID: 11773158 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters